| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/20/2011 | US8022943 Controller arrangement for an optical sensing pen |
| 09/20/2011 | US8022180 Method for preventing and treating Alzheimer's disease |
| 09/20/2011 | US8022174 C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof |
| 09/20/2011 | US8022172 Clostridial toxin substrate comprising fluorphore, lanthanide donor complex and botulin toxin recognition sequence for use in detecting clostridial protease activity |
| 09/20/2011 | US8021895 Determining presence of N-acetylmuramoyl-L-alanine amidase precursor, adiponectin, ceruloplasmin, glycoprotein, heparin and plasma retinol-binding protein; kits |
| 09/20/2011 | US8021894 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 09/20/2011 | US8021890 Colorimetric test for brake system corrosion |
| 09/20/2011 | US8021889 Chromatographic material for the absorption of proteins at physiological ionic strength |
| 09/20/2011 | US8021888 Rapid comparative genomic hybridization using acoustic surface waves |
| 09/20/2011 | US8021887 Method of measuring glycated hemoglobin concentration |
| 09/20/2011 | US8021886 Method for determining whether or not a mammal is affected with a lung cancer |
| 09/20/2011 | US8021885 Using nitrogen dioxide and oxgen mixture to monitor viscosity of engine lubricant formulations |
| 09/20/2011 | US8021884 Detecting bacteria by direct counting of structural protein units or pili by IVDS and mass spectrometry |
| 09/20/2011 | US8021876 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 09/20/2011 | US8021872 Flow cytometry for high throughput screening |
| 09/20/2011 | US8021861 Pathogenic Escherichia coli associated protein |
| 09/20/2011 | US8021860 Method for producing human antibodies to a self physiological receptor by site-directed in vitro immunization of human lymphocytes |
| 09/20/2011 | US8021855 Method of decomposing protein with sulfonic acid compound |
| 09/20/2011 | US8021853 Inhibition of the β3 subunit of L-type Ca2+ channels |
| 09/20/2011 | US8021852 Methods and compositions for detecting spermatozoa or semen in a sample |
| 09/20/2011 | US8021851 Thr51 phosphorylated HP 1β protein for the assessment of DNA damage |
| 09/20/2011 | US8021850 Universal tandem solid-phases based immunoassay |
| 09/20/2011 | US8021849 Methods and kits for the determination of sirolimus in a sample |
| 09/20/2011 | US8021848 Rapid and sensitive detection of cells and viruses |
| 09/20/2011 | US8021840 Diagnostic marker for interferon responsiveness in multiple sclerosis |
| 09/20/2011 | US8021838 Transcriptional regulation of target genes |
| 09/20/2011 | US8021837 Detection of chromosomal abnormalities associated with breast cancer |
| 09/20/2011 | US8021836 Method of diagnosing infectious disease by measuring the level of soluble TREM-1 in a sample |
| 09/20/2011 | US8021833 Method for reducing HIV viral budding by administering a VPS28-specfic antibody that disrupts Gag-TSG101-VPS28 binding interactions |
| 09/20/2011 | US8021832 Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
| 09/20/2011 | US8021831 Determination of cancer cells; analyzing gene expression; cell cycle profile |
| 09/20/2011 | US8021663 Antibodies to Lawsonia intracellularis |
| 09/20/2011 | US8021658 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 09/20/2011 | US8021644 Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis |
| 09/20/2011 | US8021631 Body fluid testing device |
| 09/20/2011 | US8021628 Structured polymer films |
| 09/20/2011 | US8021617 Flue gas monitoring and dynamic spiking for sulfur trioxide/sulfuric acid |
| 09/20/2011 | US8021614 Devices and methods for enrichment and alteration of cells and other particles |
| 09/20/2011 | US8021612 System and methods for assisting businesses in compliance with gas emissions requirements |
| 09/20/2011 | US8021570 β-peptide lyotropic liquid crystals and methods of manufacture and use thereof |
| 09/20/2011 | US8020426 Gas sorption tester for rapid screening of multiple samples |
| 09/20/2011 | CA2643663C Body fluid analysis system with priming structures integrated in test elements |
| 09/20/2011 | CA2565592C Method for characterising compounds |
| 09/20/2011 | CA2529302C System and method for coding information on a biosensor test strip |
| 09/20/2011 | CA2526087C Solid state gas sensors based on tunnel junction geometry |
| 09/20/2011 | CA2509099C Compounds and methods of use thereof for assaying lysophospholipase d activity |
| 09/20/2011 | CA2488240C Solvent extraction of vitamin a and d from fluid samples and determination of the vitamin content by means of specific monoclonal antibodies |
| 09/20/2011 | CA2478979C Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone |
| 09/20/2011 | CA2478920C Assay device |
| 09/20/2011 | CA2478547C Identification of high affinity molecules by limited dilution screening |
| 09/20/2011 | CA2476067C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 09/20/2011 | CA2473686C Novel cytokine zcytor17 ligand |
| 09/20/2011 | CA2454133C Isolation of membrane bound ligand-specific complexes |
| 09/20/2011 | CA2453628C Caged compound cleaving process |
| 09/20/2011 | CA2426348C Retrovirus isolated from humans |
| 09/20/2011 | CA2412075C Attenuated bovine respiratory syncytial virus |
| 09/20/2011 | CA2399832C Enhancing the circulating half-life of antibody-based fusion proteins |
| 09/20/2011 | CA2399733C Nucleic acid detection methods using universal priming |
| 09/20/2011 | CA2382371C Medical system, method and apparatus employing mems |
| 09/20/2011 | CA2376485C Recombinant anti-cd40 antibody and uses thereof |
| 09/20/2011 | CA2369848C Human endogenous retrovirus in breast cancer |
| 09/20/2011 | CA2367149C Combination of antibiotic and nucleic acid binding compound for bacterial antibiotic resistance |
| 09/20/2011 | CA2356009C Vascular endothelial growth factor-x |
| 09/20/2011 | CA2347248C Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 09/20/2011 | CA2329137C Novel tumor antigen useful in diagnosis and therapy of prostrate and colon cancer |
| 09/20/2011 | CA2319784C Methods for predicting pregnancy outcome in a subject by hcg assay |
| 09/20/2011 | CA2319700C Methods of identifying genes involved in enhanced wound healing in mice |
| 09/20/2011 | CA2262403C Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
| 09/20/2011 | CA2217522C Isolated frpb nucleic acid molecule and vaccine |
| 09/20/2011 | CA2115828C Calcium receptor active molecules |
| 09/15/2011 | WO2011113071A1 Measurement circuit for a breath alcohol device |
| 09/15/2011 | WO2011113047A2 Compositions and methods for characterizing breast cancer |
| 09/15/2011 | WO2011113043A2 Sample storage for molecular and immunological detection |
| 09/15/2011 | WO2011113020A1 Measurement devices and methods for measuring analyte concentration incorporating temperature and ph correction |
| 09/15/2011 | WO2011113018A1 Measurement and control of biological time |
| 09/15/2011 | WO2011113017A2 Methods for predicting fouling tendencies of hydrocarbon containing feedstocks |
| 09/15/2011 | WO2011113007A2 Modification of a flow cell to measure adsorption kinetics under stagnation point flow and development of a setup correction procedure for obtaining adsorption kinetics at the stagnation point |
| 09/15/2011 | WO2011113004A2 Markers associated with alzheimer's disease |
| 09/15/2011 | WO2011112993A2 Methods of predicting and decreasing the risk of pregnancy loss |
| 09/15/2011 | WO2011112974A1 Method and system for the safety, analysis and supervision of insulin pump action and other modes of insulin delivery in diabetes |
| 09/15/2011 | WO2011112933A1 Methods for the treatment of non-hodgkin's lymphomas using lenalidomide, and gene and protein biomarkers as a predictor |
| 09/15/2011 | WO2011112929A2 Magnetic sensor based quantitative binding kinetics analysis |
| 09/15/2011 | WO2011112908A2 Optical particle characterization system |
| 09/15/2011 | WO2011112904A1 Method and device for detecting cellular target analytes in bodily sources using carbon nanotube thin film |
| 09/15/2011 | WO2011112894A2 Optical particle characterization system |
| 09/15/2011 | WO2011112827A2 Amplifying rare cell surface markers |
| 09/15/2011 | WO2011112792A1 Compositions and methods for determining celiac disease |
| 09/15/2011 | WO2011112749A2 Semi-invasive method for characterizing lung injury |
| 09/15/2011 | WO2011112719A1 Methods and compositions to predict and detect acute rejection |
| 09/15/2011 | WO2011112634A2 Molecular indicia of cellular constituents and resolving the same by super-resolution technologies in single cells |
| 09/15/2011 | WO2011112586A2 Methods for diagnosing feline coronavirus infections |
| 09/15/2011 | WO2011112566A2 Basigin binding proteins |
| 09/15/2011 | WO2011112281A1 System and method for alkylation process analysis |
| 09/15/2011 | WO2011112091A1 Novel glucose tolerance test and composition for use |
| 09/15/2011 | WO2011112085A1 ACTIVITY BASED PROBES (ABPs) INTERACTING WITH GLYCOSIDASES |
| 09/15/2011 | WO2011112074A1 Novel glucose tolerance test and composition for use |
| 09/15/2011 | WO2011112068A1 Lateral flow device and method of detection of nucleic acid sequence |
| 09/15/2011 | WO2011112023A2 Chip for separating blood cells |
| 09/15/2011 | WO2011111969A2 Method and device for non-invasive early diagnosis of fruit tree disease |
| 09/15/2011 | WO2011111966A2 Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses |